UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF
UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF
Recruiting · NCT06860334 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF | Bunyaviridae infectious disease, Crimean-Congo hemorrhagic fever, Infections, RNA Virus Infections, arbovirus infection, tick-borne infectious disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-08-07 | NCT06860334 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Liverpool School of Tropical Medicine | 30 |
| MEDEX | 3 |
| Medical Research Council | 28 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atatürk University | Erzurum | Turkey (Türkiye) | 2 |
| Ondokuz Mayıs University | Samsun | Turkey (Türkiye) | 10 |
| Sivas Cumhuriyet University | Sivas | Turkey (Türkiye) | 8 |